Findings From an Analysis of Patients With Monocytic and Monocytic-Like Acute Myeloid Leukemia (AML), Including AML-M4 and AML-M5, Treated With Venetoclax (Ven) Plus Azacitidine (Aza)

被引：0
|
作者：
Konopleva, Marina [1 ]
DiNardo, Courtney [2 ]
Sun, Yan [3 ]
Loghavi, Sanam [2 ]
Jung, Paul [3 ]
Potluri, Jalaja [3 ]
Dail, Monique [4 ,5 ]
Chyla, Brenda [3 ]
Pollyea, Daniel
机构：
[1] Montefiore Einstein Canc Ctr, New York, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; monocytic; venetoclax; azacitidine;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-095
引用
收藏
页码：S266 / S267
页数：2
相关论文
共 50 条
  • [41] Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database
    Stein, Eytan
    Hodzic, Sejla
    Owusu, Henry
    Pathak, Dhrubajyoti
    Zhou, Summera
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S288 - S289
  • [42] THE EFFECT OF AZACITIDINE ON HEALTH-RELATED QUALITY OF LIFE (HRQL) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE AZA-AML-001 TRIAL
    Minden, M. D.
    Dombret, H.
    Seymour, J. F.
    Stone, R. M.
    Alibhai, S.
    Nixon, A.
    Kudlac, A.
    Songer, S.
    Beach, C.
    Bartiromo, C.
    Doehner, H.
    HAEMATOLOGICA, 2015, 100 : 40 - 41
  • [43] UPDATED RESULTS FROM A PHASE 2 STUDY OF PRACINOSTAT (P) IN COMBINATION WITH AZACITIDINE (AZA) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Garcia-Manero, G.
    Atallah, E.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Esquibel, V.
    Wood, K.
    Medeiros, B.
    HAEMATOLOGICA, 2015, 100 : 216 - 216
  • [44] A highly unusual case of Acute Myeloid Leukemia (AML) M5a: Atypical clinical and cytogenetic findings.
    Rossbach, HC
    Glaskova, L
    Dumont, DP
    Chamizo, W
    Barbosa, J
    Sutcliffe, MJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 239 - 239
  • [45] Real World Data on Clinical Outcomes of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated With Hypomethylating Agents (HMA) Plus Shorter Duration of Venetoclax (VEN) at a General Hospital
    Khan, Hina
    Yohannan, Binoy
    Cervoni-Curet, Frances
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S262 - S262
  • [46] Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b):: a study of 124 patients
    Haferlach, T
    Schoch, C
    Schnittger, S
    Kern, W
    Löffler, H
    Hiddemann, W
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 426 - 431
  • [47] Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry
    Labrador, Jorge
    la Fuente, Adolfode
    Martinez-Cuadron, David
    Rodriguez-Veiga, Rebeca
    Serrano, Josefina
    Tormo, Mar
    Perez-Simon, Jose
    Ramos, Fernando
    del Castillo, Teresa Bernal
    Lopez-Pavia, Maria
    Trigo, Fernanda
    Sanchez, Pilar Martinez
    Rodriguez-Gutierrez, Juan Ignacio
    Rodriguez, Carlos
    Gil, Cristina
    Garcia, Daniel
    Vives, Susana
    Foncillas, Maria Angeles
    Encinas, Manuel Perez
    Novo, Andres
    Recio, Isabel
    Macias, Gabriela Rodriguez
    Burgues, Juan Miguel Bergua
    Concepcion, Victor Noriega
    Lavilla, Esperanza
    Perez, Alicia Roldan
    Sanz, Miguel A.
    Montesinos, Pau
    BLOOD, 2021, 138
  • [48] Outcomes of Patients (pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) and TP53 mutation/Loss Treated on the Phase 2 Study of Venetoclax (Ven) Added to Alternating Cladribine (Clad) Plus Low-Dose Cytarabine (LDAC) and Azacitidine (Aza): A Subgroup Analysis
    Senapati, Jayastu
    Loghavi, Sanam
    Reville, Patrick K.
    Daver, Naval
    Borthakur, Gautam
    DiNardo, Courtney D.
    Jabbour, Elias
    Short, Nicholas J.
    Pemmaraju, Naveen
    Maiti, Abhishek
    Issa, Ghayas C.
    Popat, Uday R.
    Alousi, Amin
    Shpall, Elizabeth J.
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2023, 142
  • [49] OVERALL SURVIVAL (SG) AND CLINICAL RESULTS IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (LMA) TREATED WITH AZACITIDINE (AZA) OR WITH INTENSIVE CHEMOTHERAPY (QI) IN AZA-AML-001
    Font Lopez, P.
    Dombret, H.
    Selleslag, D.
    Songer, S.
    Lucy Lela, M.
    Beach, C. L.
    Doeher, H.
    HAEMATOLOGICA, 2015, 100 : 22 - 23
  • [50] Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study
    Doehner, Hartmut
    Seymour, John F.
    Butrym, Aleksandra
    Wierzbowska, Agnieszka
    Selleslag, Dominik
    Lang, Jun Ho
    Cavenagh, James D.
    Kumar, Rajat
    Schuh, Andre C.
    Candoni, Anna
    Recher, Christian
    Sandhu, Irwindeep
    Bernal del Castillo, Teresa
    Al-Ali, Haifa Kathrin
    Martinelli, Giovanni
    Falantes, Jose
    Stone, Richard M.
    Minden, Mark D.
    McIntyre, Heidi
    Songer, Stephen
    Lucy, Lela M.
    Beach, C. L.
    Dombret, Herve
    BLOOD, 2014, 124 (21)
12345